Institutul Clinic Fundeni

Bucharest, Bucharest 22328

1 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Inflammation, Neurogenic Detrusor Overactivity

Studies at this site

• Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed